194 related articles for article (PubMed ID: 38672477)
1. The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2.
Manou D; Golfinopoulou MA; Alharbi SND; Alghamdi HA; Alzahrani FM; Theocharis AD
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672477
[TBL] [Abstract][Full Text] [Related]
2. Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer.
Zhu Y; Lam AKY; Shum DKY; Cui D; Zhang J; Yan DD; Li B; Xu WW; Lee NPY; Chan KT; Law S; Tsao SW; Cheung ALM
Theranostics; 2021; 11(6):2722-2741. PubMed ID: 33456569
[No Abstract] [Full Text] [Related]
3. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
4. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
[TBL] [Abstract][Full Text] [Related]
5. Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.
Bouris P; Manou D; Sopaki-Valalaki A; Kolokotroni A; Moustakas A; Kapoor A; Iozzo RV; Karamanos NK; Theocharis AD
Matrix Biol; 2018 Dec; 74():35-51. PubMed ID: 29842969
[TBL] [Abstract][Full Text] [Related]
6. Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner.
Guo JY; Hsu HS; Tyan SW; Li FY; Shew JY; Lee WH; Chen JY
Oncogene; 2017 Apr; 36(17):2457-2471. PubMed ID: 27819672
[TBL] [Abstract][Full Text] [Related]
7. Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone.
He Y; Cheng D; Lian C; Liu Y; Luo W; Wang Y; Ma C; Wu Q; Tian P; He D; Jia Z; Lv X; Zhang X; Pan Z; Lu J; Xiao Y; Zhang P; Liang Y; Yang Q; Hu G
Cell Death Dis; 2021 Sep; 12(10):868. PubMed ID: 34556636
[TBL] [Abstract][Full Text] [Related]
8. Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential.
Manou D; Bouris P; Kletsas D; Götte M; Greve B; Moustakas A; Karamanos NK; Theocharis AD
Matrix Biol Plus; 2020 May; 6-7():100033. PubMed ID: 33543029
[TBL] [Abstract][Full Text] [Related]
9. KDELR2 Promotes Glioblastoma Tumorigenesis Targeted by HIF1a via mTOR Signaling Pathway.
Liao Z; She C; Ma L; Sun Z; Li P; Zhang X; Wang P; Li W
Cell Mol Neurobiol; 2019 Nov; 39(8):1207-1215. PubMed ID: 31342232
[TBL] [Abstract][Full Text] [Related]
10. SRGN Promotes Colorectal Cancer Metastasis as a Critical Downstream Target of HIF-1α.
Xu Y; Xu J; Yang Y; Zhu L; Li X; Zhao W
Cell Physiol Biochem; 2018; 48(6):2429-2440. PubMed ID: 30121667
[TBL] [Abstract][Full Text] [Related]
11. Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
Park JW; Wollmann G; Urbiola C; Fogli B; Florio T; Geley S; Klimaschewski L
Neuro Oncol; 2018 Jul; 20(8):1044-1054. PubMed ID: 29635363
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling.
Manou D; Karamanos NK; Theocharis AD
Semin Cancer Biol; 2020 May; 62():108-115. PubMed ID: 31279836
[TBL] [Abstract][Full Text] [Related]
13. A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
Al-Mayhani TF; Heywood RM; Vemireddy V; Lathia JD; Piccirillo SGM; Watts C
Neuro Oncol; 2019 Jun; 21(6):719-729. PubMed ID: 30590711
[TBL] [Abstract][Full Text] [Related]
14. Serglycin as part of IL-1β induced inflammation in human chondrocytes.
Scuruchi M; D'Ascola A; Avenoso A; Mandraffino G G; Campo S S; Campo GM
Arch Biochem Biophys; 2019 Jul; 669():80-86. PubMed ID: 31145901
[TBL] [Abstract][Full Text] [Related]
15. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocytes Up-regulate the Invasive Activity of Glioblastoma Cells
Kawashima T; Yashiro M; Kasashima H; Terakawa Y; Uda T; Nakajo K; Umaba R; Tanoue Y; Tamrakar S; Ohata K
Anticancer Res; 2019 Feb; 39(2):577-584. PubMed ID: 30711932
[TBL] [Abstract][Full Text] [Related]
17. lncRNA SNHG3 facilitates acute myeloid leukemia cell growth via the regulation of miR-758-3p/SRGN axis.
Peng L; Zhang Y; Xin H
J Cell Biochem; 2020 Feb; 121(2):1023-1031. PubMed ID: 31452272
[TBL] [Abstract][Full Text] [Related]
18. NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.
Al-Mayhani MT; Grenfell R; Narita M; Piccirillo S; Kenney-Herbert E; Fawcett JW; Collins VP; Ichimura K; Watts C
Neuro Oncol; 2011 Aug; 13(8):830-45. PubMed ID: 21798846
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1.
Pu W; Nassar ZD; Khabbazi S; Xie N; McMahon KA; Parton RG; Riggins GJ; Harris JM; Parat MO
J Neurooncol; 2019 Jun; 143(2):207-220. PubMed ID: 30949900
[TBL] [Abstract][Full Text] [Related]
20. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
